321
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Letter to the Editor: “Diabetic Nephropathy: Has the Time Come to Move beyond Plasma Creatinine?”

&
Pages 525-526 | Published online: 07 Jul 2009

Diabetic nephropathy is the leading cause of kidney disease in patients with end stage renal disease and affects 40% of type 1 and type 2 diabetic patients. The major feature of diabetic nephropathy is an increase in urinary albumin excretion (UAE) in the absence of other renal diseases. Diabetic nephropathy is categorized into two stages: microalbuminuria (UAE >20 µg/min and ≤199 µg/min) and macroalbuminuria (UAE 200 µg/min). In patients with type 2 diabetes or features of metabolic syndrome, screening for microalbuminuria should be performed at diagnosis and yearly thereafter. For type 1 diabetes, screening should be performed five years after diagnosis and then yearly. However, some diabetic patients were found to have normal UAE and a significant reduction in GFR.[Citation[1–3]]

The estimation of GFR is an indispensable tool to determine renal function in not only diabetic patients, but in the general population as well. In patients with type 2 diabetes in the NHANES III (Third National Health and Nutrition Examination Survey), low GFR (<60 mL · min−1 · 1.73 m−2) was present in 30% of patients in the absence of micro- or macroalbuminuria and retinopathy.[Citation[1]] There are some patients with either type 1 or type 2 diabetes who have decreased glomerular filtration rate (GFR) in the presence of normal UAE.[Citation[2],Citation[3]] In patients with type 1 diabetes, this phenomenon seems to be more common among female patients with longstanding diabetes, hypertension, and/or retinopathy.[Citation[2]] These studies indicate that normoalbuminuria does not protect from a decrease in GFR in type 1 and type 2 diabetic patients. Therefore, GFR should be routinely estimated and UAE routinely measured for a proper screening of diabetic nephropathy. The recommended equation for GFR estimation by the National Kidney Foundation is the Modified Diet in Renal Disease (MDRD) equation: GFR (ml · min−1 · 1.73 m−2) = 186 × [serum creatinine (mg/dL)−1.154 × age (years)−0.203 × (0.742 if female) × (1.210 if African American)].[Citation[4]] The MDRD is readily accessible online at http://www.kidney.org/klsprofessionals/gfr_calculator.cfm. The reference range of GFR values in young individuals is from 80 to 130 ml · min−1 · 1.73 m−2, declining at #10 ml · min−1 · decade−1 after 50 years of age.[Citation[5]]

On the other hand, in microalbuminuric patients, GFR remained stable in a subset of patients that showed a rapid decline in GFR levels.[Citation[6]] Patients with a more rapid GFR decline usually have more advanced diabetic glomerulopathy and worse metabolic control. Early referral to a nephrologist should be considered, especially when GFR reaches 30 ml·min−1·1.73m−2.[Citation[6]] Therefore, GFR is the best parameter of overall kidney function and should be measured or estimated in micro- and macroalbuminuria diabetic patients.

References

  • MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195–200, [INFOTRIEVE]
  • Kramer HJ, Nguyen Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients is associated with more advanced diabetic lesions. Diabetes 2003; 52: 1036–1040
  • Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273–3277, [INFOTRIEVE], [CROSSREF]
  • Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med. 2003; 139: 137–147, [INFOTRIEVE]
  • Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand. J. Clin. Lab. Invest. 1981; 41: 611–616, [INFOTRIEVE]
  • Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000; 49: 476–484, [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.